Skip to main content
Menu
US

AlphaLISA SureFire Ultra Human Total MYD88 Detection Kit, 100 Assay Points

The AlphaLISA™ SureFire® Ultra™ Human Total MYD88 assay is a sandwich immunoassay for quantitative detection of total MYD88 in cellular lysates using Alpha technology.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Feature Specification
Application Cell Signaling
Sample Volume 30 µL

The AlphaLISA™ SureFire® Ultra™ Human Total MYD88 assay is a sandwich immunoassay for quantitative detection of total MYD88 in cellular lysates using Alpha technology.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Product Variants
Unit Size: 100 Assay Points
Part #:
ALSU-TMYD-A-HV
List Price
USD 694.00
Unit Size: 500 Assay Points
Part #:
ALSU-TMYD-A500
List Price
USD 2,346.00
Unit Size: 10,000 Assay Points
Part #:
ALSU-TMYD-A10K
List Price
USD 14,270.00
Unit Size: 50,000 Assay Points
Part #:
ALSU-TMYD-A50K
List Price
USD 46,060.00

Overview

Toll-like or interleukin-1 receptors (TLR/IL-1R) signaling is mediated by Myeloid Differentiation Factor 88 (MYD88), a crucial adapter that mediates the onset of the innate immune response and the generation of proinflammatory cytokines that inhibit pathogens and activate adaptive immunity. While a host's ability to fend off pathogenic infection depends on MYD88, disruption of its abundance can result in autoimmune disorders. One important mechanism for stopping the production of cytokines is the degradation of MYD88.

The AlphaLISA SureFire Ultra Human Total MYD88 Detection Kit is a sandwich immunoassay for the quantitative detection of total MYD88 in cellular lysates, using Alpha technology.

Formats:

  • The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
  • The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
  • The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
  • The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Ultra kits are compatible with:

  • Cell and tissue lysates
  • Antibody modulators
  • Biotherapeutic antibodies

Alpha SureFire kits can be used for:

  • Cellular kinase assays
  • Receptor activation studies
  • High-throughput drug screening

Specifications

Application
Cell Signaling
Automation Compatible
Yes
Brand
AlphaLISA SureFire Ultra
Detection Modality
Alpha
Lysis Buffer Compatibility
Lysis Buffer
Molecular Modification
Total
Product Group
Kit
Sample Volume
30 µL
Shipping Conditions
Shipped in Blue Ice
Target
MYD88
Target Class
Phosphoproteins
Target Species
Human
Technology
Alpha
Therapeutic Area
Autoimmunity
Unit Size
100 Assay Points

Assay validation

Validation of MYD88 Total assay in THP-1 derived macrophages and Karpas299 cells

THP-1 cells were seeded in a 96-well culture plate (80,000 cells/well) in complete medium, treated with 100 nM PMA and incubated for 24 hours at 37°C, 5% CO2. The cells were further treated with increasing concentrations of LPS for 24 hours. After treatment, the cells were washed in HBSS and lysed with 100 µL of lysis buffer for 10 minutes at RT with shaking at 350 rpm. Lysates were further diluted 1:5 in lysis buffer before proceeding to the detection step. MYD88 Total and NFkB Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 1,600 cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision Nexus™ using standard AlphaLISA settings.

Validation of MYD88 Total assay in THP-1 derived macrophages and Karpas299 cells

Karpas299 cells were harvested, washed in HBSS + 0.1% BSA and seeded in a 96-well culture plate (100,000 cells/well) in HBSS + 0.1% BSA. The cells were further treated with increasing concentrations of IL-1b for 10 minutes. 

After treatment, the cells were lysed with 50 µL of 5X lysis buffer for 10 minutes at RT with shaking at 350 rpm. MYD88 Total, IRAK4 Phospho (Thr345/Ser346) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision Nexus using standard AlphaLISA settings.

Validation of MYD88 Total assay in THP-1 derived macrophages and Karpas299 cells

Assay specificity/selectivity

Specificity of MYD88 Total assay

Total MYD88 protein levels were assessed in A549 wild type (WT) cells and MYD88 knockout (KO) A549 cells. Both cell lines were grown to confluency in a T175 flask in complete medium. Each flask was lysed in 4 mL of lysis buffer for 10 minutes at RT with shaking at 350 rpm. Lysates were serially diluted in lysis buffer and evaluated for MYD88 Total as well as Cofilin Total levels to ensure normalization (data not shown). For the detection step, 10 µL of cell lysate were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision Nexus using standard AlphaLISA settings. As expected, MYD88 was detected in the WT-A549 cells but not in the MYD88-KO cell line.

Knockout validation of MYD88 Total

HeLa cells were seeded at different densities in a 96-well plate (200 µL/well) in complete culture medium and incubated overnight at 37°C, 5% CO2. Cells were siRNA treated with 50 µL of a mix of transfection reagent (Santa Cruz, sc-29528)/MYD88 siRNA (Santa Cruz, sc- 35986) or a mix of transfection reagent/siRNA control (Santa Cruz, sc-37007) for 48 hours. After treatment, the cells were lysed with 100 µL of lysis buffer for 10 minutes at RT with shaking at 350 rpm. MYD88 Total levels were evaluated by AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision Nexus using standard AlphaLISA settings.

siRNA validation of MYD88 Total

Resources

Are you looking for resources, click on the resource type to explore further.

1-2 of 2 Resources
Technical Note Icon
Technical Note
AlphaLISA EZH2 Histone H3-Lysine 27 N-methyltransferase assay

Lysine 27 Dimethylation Detection with AlphaLISA Technology

In this technical note discover how AlphaLISA immunodetection assay...

Technical Note Icon
Technical Note
AlphaLISA G9a Histone H3-Lysine N-methyltransferase assay

Quantification of Histone H3 Lysine 9 Di-Methylation Using AlphaLISA Assay

In this technical note discover how The AlphaLISA assay...

Scroll Icon